Work

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer

Year: 2015

Type: article

Study design: Clinical Trial

Source: Targeted Oncology

DOI: 10.1007/s11523-015-0394-5

Authors: John Sarantopoulos, Monica M. Mita, Michael J. Birrer, Lee D. Cranmer, Luis T. Campos, Xiaoping Zhang, Penelope Bristow, Hidekuni Kaito, Vincent Strout, Luis H. Camacho

Institutions: The University of Texas at San Antonio Health Science Center, Cedars-Sinai Medical Center, Harvard University, Massachusetts General Hospital, University of Arizona Cancer Center, Kyowa Kirin (Japan)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Mays Cancer Center at UT Health SA

OpenAlex ID: W1850427692

FWCI: 2.428

Cites: 45

Cited by: 14

Related to: 10